IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
INVO Fertility, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.60+0.04 (+7.78%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$29.4710 (−98.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
INVO Fertility, Inc. reported revenue of $7.53M for the twelve months to Jun 30, 2026. Free cash flow was -$7.06M.
Revenue
$7.53M
TTM Q2 2026
Operating income
-$5.93M
TTM Q2 2026
Free cash flow
-$7.06M
FY2025
EPS, diluted
-$214.64
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.56M
- P/E ratio
- –
- Price to sales
- 0.21
- Price to book
- 0.09
- Dividend yield
- –
- Free cash flow yield
- -453.07%
Fundamentals
- Revenue
- $7.53M
- Net income
- -$6.95M
- EPS, diluted
- -$214.64
- Free cash flow
- -$7.06M
- Book value per share
- $6.36
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$7.53M
Gross profit
–
Operating income
-$5.93M
Net income
-$6.95M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months